Intellia Therapeutics Inc (NASDAQ:NTLA)

Delayed Data
As of Dec 08
 -0.78 / -2.62%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 24 analysts offering 12-month price forecasts for Intellia Therapeutics Inc have a median target of 72.00, with a high estimate of 145.00 and a low estimate of 29.00. The median estimate represents a +148.28% increase from the last price of 29.00.

Analyst Recommendations

The current consensus among 27 polled investment analysts is to Buy stock in Intellia Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 22

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -3.91%
Growthannually 13.84%


Growthquarterly -0.69%
Growthannually -5.13%
Key to the earnings and sales forecast charts.